The clinical utility of autologous tumor lysate-loaded dendritic cell vaccination for patients with glioma: A systematic review and meta-analysis.
Mohammad Amin HabibiMohammad Sina MirjaniMuhammad Hussain AhmadvandPouria DelbariShayan ArabPoriya MinaeeSeyedMohammad EaziSajjad AhmadpourPublished in: Asia-Pacific journal of clinical oncology (2024)
In gliomas, DC vaccinations show a temporary efficacy; stability is more prevalent than regression. Impacts favor decreased resistance to early disease. Enhancing efficacy remains critical. Early therapy can be enhanced by appropriate supplementary therapy integration.